The Sharp Financial Group Advises Marketshare Movers in Sale to United BioSource
The Sharp Financial Group (“Sharp”) Advises Marketshare Movers (“MSM”) in Sale to United BioSource LLC (“UBC”)
Horsham, PA - March 2022 - Sharp, an integrated financial management firm that uniquely unifies business advisory, accounting and tax, investment banking, wealth management and family office services, today announced the transaction that joined MSM with biopharmaceutical market leader UBC, a portfolio company of Avista Capital Partners.
Through its leading middle-market investment bank, Sharp Capital Advisors, Sharp served as the exclusive financial advisor to MSM on the transaction.
“The Sharp team provided significant insight and comprehensive support during the transaction process. They were professional, extremely knowledgeable of the sector, and worked well with UBC’s team and legal teams. The Sharp team was invaluable to achieving the transaction objectives while finding the best possible long-term partner in UBC/Avista,” said Kevin Kane, Founder, MSM.
# # #
See complete details on the UBC website
Advisor Contact:
Michael Verrill
p: 215.659-2130 e: mverrill@sharpllc.com